Women with MS face a significantly higher risk of mental health problems during and after pregnancy than those without MS, a study finds.

The FDA approved an oral combination of meloxicam and rizatriptan (Symbravo) to treat adults with acute migraine with or ...

Dr. Hauser's dedication to patient-centered care and his expertise in advancing scientific discovery make him uniquely qualified ...

Clinical trials demonstrated that a single dose of Symbravo provides rapid migraine relief, sustains efficacy for up to 48 ...

South San Francisco, CA, January 30, 2025 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has awarded nearly ...

Researchers have identified two biomarkers that can reveal how sensitive an individual is to pain, and may offer new approaches for treating pain... | Clinical And Molecular Dx ...

Axsome Therapeutics (AXSM) will host a virtual investor event and conference call at 8:00 AM Eastern Time to discuss the U.S. Food and Drug ...

A major trial in frontotemporal dementia patients has found that oxytocin can help improve symptoms of apathy. A new study led by Western researchers suggests that frequent treatment with intranasal o ...

Bassett Healthcare Network welcomed seven new health care practitioners during January, according to a news release Thursday, Jan. 30. Dr. Ramesh Cherukuri joined Bassett as division chief of ...

Investigators have discovered that activity in two widely distributed brain networks previously considered separate are ...

Los Angeles-based Cedars-Sinai has partnered with Oxford Science Enterprises, an independent investment company affiliated with the University of Oxford.

Clinically Meaningful Benefit Observed at Both ATH434 Doses Studied –– Achieved Statistical Significance with Up to 48% Slowing of Clinical ...